Nan Fang Du Shi Bao·2025-05-26 13:00Core Viewpoint - Fourier, a humanoid robot company based in Shanghai, has achieved a pre-investment valuation of 8 billion RMB, becoming a "unicorn" [1] Group 1: Investment and Corporate Strategy - Runyang Technology plans to invest up to 300 million RMB in Fourier, with an investment intention agreement already signed [1] - The investment aims to meet the strategic development needs of Runyang Technology, expand its business scope, and enhance its overall competitiveness while maintaining stable growth in its core business [1] Group 2: Company Background and Shareholding Structure - Fourier was founded in July 2015 and recently completed an E-round financing of nearly 800 million RMB on January 7, 2023, with participation from various investment institutions [1] - The founder and CEO, Gu Jie, is the largest shareholder, holding 11.556% of the shares directly, with additional indirect holdings through various partnerships [2][3] Group 3: Product Development and Market Focus - Fourier has released two models of the GR series humanoid robots and is focusing on the rehabilitation scene as the next phase of its embodied intelligence business [1][4] - The company has entered over 3,000 hospitals globally with its rehabilitation robots, emphasizing the importance of interaction between patients and machines [4] Group 4: Challenges in the Medical Field - The implementation of embodied intelligence technology in healthcare is more challenging than in other sectors due to a lack of interdisciplinary talent and high policy barriers [6] - Medical institutions are currently cautious about adopting embodied intelligence robots, preferring to wait for proven efficacy and compliance with national standards [7]